Experimental pill: Revumenib shows potential in leukemia treatment
This week, scientists describe a novel experimental pill that may be able to help patients with difficult-to-treat leukemia.
In the phase I trial, nearly half of the patients responded to the treatment, known as revumenib, and about a…